Company profile: Hemostatix
1.1 - Company Overview
Company description
- Provider of thermal scalpel systems delivering surgical precision, visualization, and control. Products include Hemostatix Thermal Scalpel using thermal energy to seal blood vessels while cutting without electric current; Precision 8400 Controller maintaining blade temperature via Virtual Temperature Sensing; and a scalpel handle with temperature, incision, angle, and pressure control plus visual/tactile feedback.
Products and services
- Precision 8400 Controller: Software-driven, it maintains blade temperature within narrow limits using Virtual Temperature Sensing, adapting to tissue type and cutting speed for consistent temperature-controlled cutting
- Hemostatix Thermal Scalpel: Non-electric, it uses thermal energy to seal blood vessels while cutting, enabling precise anatomical dissection without any electric current and optimizing surgical outcomes safely
- Scalpel Handle: Ergonomic, it enables control over blade temperature, incision rate, angle, and pressure, delivering visual and tactile feedback during surgery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hemostatix
Endocontrol
HQ: France
Website
- Description: Provider of robotic assistance for laparoscopic surgery, working with and for surgeons to develop collaborative robots (cobots) for laparoscopic procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endocontrol company profile →
SafeAir
HQ: Switzerland
Website
- Description: Provider of design, development and manufacture of innovative surgical smoke evacuation solutions, offering a complete Smoke Evacuation System comprising the SafeAir Smoke Pencil with integrated smoke evacuation function and the powerful, silent SafeAir Smoke Evacuator.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SafeAir company profile →
Dextera Surgical
HQ: United States
Website
- Description: Provider of automated anastomosis devices that replace hand-sewn vessel connections in coronary artery bypass graft (CABG) and other grafting surgeries, offering the MicroCutter 5/80 five-millimeter surgical stapler with 80 degrees of articulation for minimally invasive and robotic-assisted procedures, and C-Port distal and PAS-Port proximal anastomosis systems for consistent, reliable connections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dextera Surgical company profile →
Microsure
HQ: The Netherlands
Website
- Description: Provider of microsurgery robotics, including the MUSA-3 robot system with tremor filtration, an ergonomic surgeon console with joystick control and digital/hybrid microscope viewing, and compatibility with preferred microsurgical instruments. The system includes a robotic arm cart supporting two arms for high-precision, stable tasks across different wound orientations, helping microsurgeons overcome physical limitations and enhance performance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Microsure company profile →
Medisiss
HQ: United States
Website
- Description: Provider of registered third-party medical device reprocessing services for single-use devices (SUDs); acquired by Medline Industries in 2012.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medisiss company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hemostatix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hemostatix
2.2 - Growth funds investing in similar companies to Hemostatix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hemostatix
4.2 - Public trading comparable groups for Hemostatix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →